Üropsikiyatriye Giriş ve Biyopsikososyal Yaklaşım

Authors

Bilal Sağlıyan
https://orcid.org/0000-0002-6563-3058

Synopsis

Üropsikiyatri; ürolojik semptomlar, merkezi ve otonom sinir sistemi işleyişi, psikiyatrik belirtiler ve psikososyal etkenler arasındaki çift yönlü ilişkiyi inceleyen disiplinlerarası bir alandır. Kronik pelvik ağrı, aşırı aktif mesane, alt üriner sistem semptomları, mesane ağrı sendromu, cinsel işlev bozuklukları ve üroonkolojik süreçler; biyolojik, psikolojik ve sosyal bileşenlerin iç içe geçtiği klinik tablolar oluşturmaktadır. Bu nedenle organ odaklı biyomedikal yaklaşım, özellikle fonksiyonel ve kronik ürolojik yakınmaların değerlendirilmesinde tek başına yetersiz kalabilmektedir. Üropsikiyatrik değerlendirme, hastanın yalnızca anatomik veya laboratuvar bulgularını değil; ağrı deneyimini, uyku düzenini, duygudurumunu, anksiyete düzeyini, travma öyküsünü, cinsel işlevlerini, sosyal desteğini ve günlük işlevselliğini birlikte ele almalıdır. Kronik stres, anksiyete, depresyon, travmatik yaşantılar ve merkezi duyarlılaşma; beyin-mesane ve beyin-bağırsak-mesane eksenleri üzerinden ürolojik semptomların ortaya çıkmasına veya sürmesine katkıda bulunabilmektedir. Ürolojik ve pelvik sağlıkla ilişkili birçok klinik tablo, yalnızca lokal organ patolojisi üzerinden açıklanamayacak kadar çok boyutludur. Üroloji, psikiyatri, algoloji, fizik tedavi ve rehabilitasyon alanlarının iş birliği içinde çalıştığı multidisipliner yaklaşım; semptom kontrolünün yanı sıra yaşam kalitesinin, işlevselliğin ve ruhsal iyilik hâlinin korunması açısından temel önemdedir.

References

Xiao X, Song H, Sang T, Wu Z, Xie Y, Yang Q. Analysis of real-world implementation of the biopsychosocial approach to healthcare: evidence from a combination of qualitative and quantitative methods. Frontiers in psychiatry. 2021;12:725596.

Van den Ende M, Apostolidis A, Sinha S, Kheir GB, Mohamed-Ahmed R, Selai C, et al. Should We Be Treating Affective Symptoms, Like Anxiety and Depression Which May Be Related to LUTD in Patients With OAB? ICI-RS 2024. Neurourology and Urodynamics. 2025;44(3):661-7.

Vyas N, Brunckhorst O, Fox L, Van Hemelrijck M, Muir G, Stewart R, et al. Undergoing radical treatment for prostate cancer and its impact on wellbeing: A qualitative study exploring men’s experiences. PLoS One. 2022;17(12):e0279250.

Dorozhenok IY, Gadgieva Z, Grigoryan V, Shvidkaya A. Psyhosomatic aspects of dysuria in women from the perspective of an interdisciplinary approach. Urologiia. 2019(4):163-7.

Nickel JC, Tripp D, Gordon A, Pontari M, Shoskes D, Peters KM, et al. Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada. Reviews in urology. 2011;13(1):39.

Leue C, Kruimel J, Vrijens D, Masclee A, Van Os J, Van Koeveringe G. Functional urological disorders: a sensitized defence response in the bladder–gut–brain axis. Nature Reviews Urology. 2017;14(3):153-63.

Miftahof RN, Cyron CJ. The Brain–Bladder Axis in Tissue Growth and Remodelling: IOP Publishing; 2021.

Shy M, Fung S, Boone TB, Karmonik C, Fletcher SG, Khavari R. Functional magnetic resonance imaging during urodynamic testing identifies brain structures initiating micturition. The Journal of urology. 2014;192(4):1149-54.

Liu Z-q, Yang X-y, Chen J-h, Ge S-c, Dai S-x, Zhu S-h, et al. From dysbiosis to precision therapy: decoding the gut-bladder axis in bladder carcinogenesis. Frontiers in Oncology. 2025;15:1630726.

Hardy CC, Korstanje R. Aging and urinary control: Alterations in the brain–bladder axis. Aging cell. 2023;22(12):e13990.

Van Batavia JP, Butler S, Lewis E, Fesi J, Canning DA, Vicini S, et al. Corticotropin-releasing hormone from the pontine micturition center plays an inhibitory role in micturition. Journal of Neuroscience. 2021;41(34):7314-25.

Bradley CS, Nygaard IE, Mengeling MA, Torner JC, Stockdale CK, Booth BM, et al. Urinary incontinence, depression and posttraumatic stress disorder in women veterans. American journal of obstetrics and gynecology. 2012;206(6):502. e1-. e8.

Bradley CS, Nygaard IE, Hillis SL, Torner JC, Sadler AG. Longitudinal associations between mental health conditions and overactive bladder in women veterans. American Journal of Obstetrics and Gynecology. 2017;217(4):430. e1-. e8.

Shin YS, Soni KK, Lee DY, Kam SC. The relationship between depression, anxiety and lower urinary tract symptoms in men. Prostate International. 2024;12(2):86-9.

Zhou Z, Xu L, Wu H, Hong H. Anxiety-induced overactive bladder: The role of oxidative stress and NF-κB signaling pathway with Hsp90 as a potential biomarker. Molecular Medicine Reports. 2026;33(3):85.

Lee Y-F, Ho P-S, Liang C-S. Brain–bladder axis: a case of anxiety-associated haematuria.

Psychiatry and Clinical Psychopharmacology. 2018;28(3):349-51.

Spironelli C, Marino M, Mantini D, Montalti R, Craven AR, Ersland L, et al. fMRI fluctuations within the language network are correlated with severity of hallucinatory symptoms in schizophrenia. Schizophrenia. 2023;9(1):75.

Razzak AN, Orlando NA, Angelette A, Kumar V, Anderson DJ, Hasoon J, et al. Rare mental health disorders affecting urologic care: a comprehensive review. Health Psychology Research. 2022;10(4):38674.

Mahintorabi S, Jones MK, Harris LM, Zahiroddin A. Religious observance and obsessive compulsive washing among Iranian women. Journal of obsessive-compulsive and related disorders. 2015;7:35-42.

Liao Y, Li Y, Wang X, Pu F, Yong G, Ming W, et al. Comparative study between female patients with functional dyspepsia accompanied by abnormal urinalysis and those with urinary tract infections: a retrospective case-control study. Scientific Reports. 2026.

Liu L. Exploring the association between overactive bladder (OAB) and cognitive decline: mediation by depression in elderly adults, a NHANES weighted analysis. Scientific Reports. 2025;15(1):3669.

Araklitis G, Robinson D, Cardozo L. Cognitive effects of anticholinergic load in women with overactive bladder. Clinical Interventions in Aging. 2020:1493-503.

Li T, Di X, Li Y, Wei J, Liao B, Wang K. The association between depression and overactive bladder: a cross-sectional study of NHANES 2011–2018. International Urogynecology Journal. 2025;36(2):373-80.

Chancellor MB, Lucioni A, Staskin D. Oxybutynin-associated cognitive impairment: evidence and implications for overactive bladder treatment. Urology. 2024;186:123-9.

Welk B, Richardson K, Panicker JN. The cognitive effect of anticholinergics for patients with overactive bladder. Nature Reviews Urology. 2021;18(11):686-700.

Dmochowski RR, Thai S, Iglay K, Enemchukwu E, Tee S, Varano S, et al. Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourology and urodynamics. 2021;40(1):28-37.

Kotochinsky M, Mora L, Carrazzoni Godoi D, da Silva FMTdFG, Guedes Amorim K, Fernandes Oliveira Amador W, et al. Risk of dementia in patients treated with anticholinergics for overactive bladder syndrome: a systematic review and meta-analysis. Neurological Sciences. 2025;46(12):6217-26.

Dydyk AM, Singh C, Gupta N. Chronic pelvic pain. StatPearls [Internet]: StatPearls Publishing; 2025.

Sandler MD, Ledesma B, Thomas J, Ben-Ezra L, Lokeshwar SD, Paz LA, et al. Biopsychosocial approach to male chronic pelvic pain syndrome: recent treatments and trials. Sexual medicine reviews. 2024;12(1):59-66.

Horner PJ, Connor E, Williams S, Butterly J, Crofts M. A holistic biopsychosocial management approach for cis-gender males with chronic pelvic pain syndrome attending sexual health services: a retrospective case review. Sexually Transmitted Infections. 2024;100(2):113-5.

Shoskes DA, Nickel JC, Kattan MW. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology. 2010;75(6):1249-53.

Shoskes DA, Nickel JC, Dolinga R, Prots D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology. 2009;73(3):538-42.

Laranja WW, Sanches BC, Voris BR, Alonso JC, Simões FA, Rejowski RF, et al. The biopsychosocial burden of prostate biopsy at the time of its indication, procedure, and pathological report. Prostate Cancer. 2019;2019(1):2653708.

Johnson S, Bradshaw A, Bresnahan R, Evans E, Herron K, Hapangama DK. Biopsychosocial approaches for the management of female chronic pelvic pain: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2025;132(3):266-77.

Meisenheimer ES, Carnevale AM. Chronic pelvic pain in women: evaluation and treatment.

American Family Physician. 2025;111(3):218-29.

Lackner JM, Jaccard J, Quigley BM, Ablove TS, Danforth TL, Firth RS, et al. Study protocol and methods for Easing Pelvic Pain Interventions Clinical Research Program (EPPIC): a randomized clinical trial of brief, low-intensity, transdiagnostic cognitive behavioral therapy vs education/support for urologic chronic pelvic pain syndrome (UCPPS). Trials. 2022;23(1):651.

Petrini L, Arendt-Nielsen L. Understanding pain catastrophizing: putting pieces together. Front Psychol. 2020; 11: 603420. 2020.

Oliveira I, Garrido MV, Carvalho H, Bernardes SF. Sensing the body matters: profiles of interoceptive sensibility in chronic pain adjustment. Pain. 2024;165(2):412-22.

Funada S, Luo Y, Uozumi R, Watanabe N, Goto T, Negoro H, et al. Multicomponent intervention for overactive bladder in women: a randomized clinical trial. JAMA network open. 2024;7(3):e241784.

Vincent K, Evans E. An update on the management of chronic pelvic pain in women.

Anaesthesia. 2021;76:96-107.

McCracken LM, Vowles KE. Acceptance and commitment therapy and mindfulness for chronic pain: model, process, and progress. American psychologist. 2014;69(2):178.

Published

November 17, 2026

License

License